Back to
VANGUARD GROUP INC
ALLR2 quarters
Position history for
VANGUARD GROUP INC's holdings in ALLARITY THERAPEUTICS INC
As of its last 13F, for Q4 2025, Vanguard Group held 246,708 shares of ALLR (Allarity Therapeutics), worth $266,445. The share count is unchanged from Q3 2025. Vanguard Group held ALLR from Q3 2025 to Q4 2025, across 2 quarterly 13F filings.
Current Value
$266,445
Current Shares
246,708
Total Value Change
-$123,354
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ALLR: Private Advisor Group, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC